Curaleaf: Non-compliant CBD statements removed from website
Photo | Google
Curaleaf's Oxford dispensary
The Massachusetts marijuana giant Curaleaf, with significant operations in Central Massachusetts, said it has removed statements from its website and social media platforms identified as non-compliant by federal regulators.
In a statement Friday, the Wakefield company responded to the U.S. Food and Drug Administration’s notice by removing statements claiming certain CBD products can treat certain diseases.
That included removing entirely the company’s hemp blog and all third-party links in it, the company said.
The company noted several products mentioned by the FDA were previously discontinued.
"Our industry needs, wants and appreciates the work the FDA is doing to ensure there is regulation and compliance in the CBD marketplace," CEO Joseph Lusardi said in a statement.
Curaleaf was warned by the FDA earlier this week for claiming on its website some CBD products sold online can treat cancer, Alzheimer’s opioid withdrawal, pain and pet anxiety.
CBD -- or cannabidiol -- is the non-psychoactive chemical in cannabis or hemp some say can help treat some ailments. Its legal status remains unclear even after Congress legalized hemp last year.
Curaleaf is one of the largest marijuana operators in the U.S. and has a large presence in the region, including a cultivation and manufacturing facility in Webster and a medical dispensary in Oxford. Other dispensaries are planned for Ware and Provincetown.
WBJ Web Partners
Most Recent
Most Recent
0 Comments